fbg, you say, "Attil, I think it would be in all our interests if Lombardo sold the company soon..."
It may be in your interests, but it would not be in mine. I bought ADXS to take on much more potential reward with much more risk than a cash out in the $20's would realize (say, $1B at current shares outstanding).
I do hope ADXS gets into the $20's so you can happily sell, but I will be holding beyond that if this company does what I believe it can do. I'm still a believer in DOC's sense that $6B is a minimum sale point, and maybe quite a bit higher depending on how the trial results develop. And I'd be happy to take as much as 33% dilution of my current position to get there. It might take 3-4 years to get there, but I can wait.
So, you see, not every investor has your investing criteria -- and not everyone has mine, I am sure. Getting to my outcome guarantees yours along the way. But, if ADXS gets sold in the $20's, well, I think that would be a "steal" from current owners. I know I would feel robbed!
On the other hand, if it goes to $1B and then flops back to zero, I'll hope you were able to cash out. And I will not be unhappy with my outcome of $0. Why? It's the bargain I made because I believe this company will either be worth a LOT or damn little....not much in between. That's what pre-revenue biotech investing is all about...and I do have a portfolio of biotechs, because you'll only win maybe 1 in 5.
News 
Market Data 
Discover 
